Note: As Retatrutide remains under investigation through ongoing clinical trials, it has not yet received MHRA approval and is not currently authorised for routine prescribing in the UK
"Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available." Novo Nordisk GoodRx
Evaluation of serum oxidative stress levels and antioxidant capacity in prediabetes
Like other chronic diseases, obesity needs a holistic approach to care that certainly can include medical intervention, such as GLP-1s, but it also needs strong patient engagement and activation
PlexusDx recommends discussing your breastfeeding timeline with your care team before starting any weight loss medication
GLP-1-based treatments are administered subcutaneously and work by supporting your bodys natural processes for appetite suppression and slowing gastric emptying, which may contribute to a feeling of fullness